The role of thallium-201 and pentavalent dimercaptosuccinic acid for staging cartilaginous tumours

International Seminars in Surgical Oncology

Volumn 1, Issue , 2004, Pages

  Choong, Peter F M ^a,c   Kunisada, Toshiyuki ^a   Slavin, John ^b   Schlicht, Stephen ^b   Hicks, Rodney ^c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOISOTOPE; SUCCIMER; THALLIUM 201;

ADOLESCENT; ADULT; AGED; ALGORITHM; ARTICLE; CANCER STAGING; CANCER SURGERY; CARTILAGE TUMOR; CHONDROSARCOMA; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT PLANNING; TUMOR BIOPSY;

EID: 18144427158     PISSN: 14777800     EISSN: None     Source Type: Journal    
DOI: 10.1186/1477-7800-1-10     Document Type: Article

References (48)

1. Coughlan B, Feliz A, Ishida T, Czerniak B, Dorfman HD: p53 expression and DNA ploidy of cartilage lesions. Hum Pathol 1995, 26:620-624.
2. Springfield DS, Gebhardt MC, McGuire MH: Chondrosarcoma: a review. Instr Course Lect 1996, 45:417-424.
3. Dirix LY, Van Oosterom AT: Chondrosarcoma and other rare bone sarcomas. Curr Opin Oncol 1991, 3:694-699.
4. Varma DG, Ayala AG, Carrasco CH, Guo SQ, Kumar R, Edeiken J: Chondrosarcoma: MR imaging with pathologic correlation. Radiographics 1992, 12:687-704.
5. Golfieri R, Baddeley H, Pringle JS, Leung AW, Greco A, Souhami R, Kemp H: Primary bone tumors. MR morphologic appearance correlated with pathologic examinations. Acta Radiol 1991, 32:290-298.
6. Woertler K, Lindner N, Gosheger G, Brinkschmidt C, Heindel W: Osteochondroma: MR imaging of tumor-related complications. Eur Radiol 2000, 10:832-840.
7. Letson GD, Muro-Cacho CA: Genetic and molecular abnormalities in tumors of the bone and soft tissues. Cancer Control 2001, 8:239-251.
8. Ishida T, Kikuchi F, Machinami R: Histological grading and morphometric analysis of cartilaginous tumours. Virchows Arch A Pathol Anat Histopathol 1991, 418:149-155.
9. Inwards CY, Unni KK: Classification and grading of bone sarcomas. Hematol Oncol Clin North Am 1995, 9:545-569.
10. Bertoni F, Bacchini P: Classification of bone tumors. Eur J Radiol 1998, 27 Suppl 1:S74-6.
11. Hasegawa T, Seki K, Yang P, Hirose T, Hizawa K, Wada T, Wakabayashi J: Differentiation and proliferative activity in benign and malignant cartilage tumors of bone. Hum Pathol 1995, 26:838-845.
12. Hicks RJ: Nuclear medicine techniques provide unique physiologic characterization of suspected and known soft tissue and bone sarcomas. Acta Orthop Scand Suppl 1997, 273:25-36.
13. Murphey MD, Flemming DJ, Boyea SR, Bojescul JA, Sweet DE, Temple HT: Enchondroma versus chondrosarcoma in the appendicular skeleton: differentiating features. Radiographics 1998, 18:1213-37; quiz 1244-5..
14. De Beuckeleer LH, De Schepper AM, Ramon F: Magnetic resonance imaging of cartilaginous tumors: is it useful or necessary? Skeletal Radiol 1996, 25:137-141.
15. Geirnaerdt MJ, Bloem JL, Eulderink F, Hogendoorn PC, Taminiau AH: Cartilaginous tumors: correlation of gadolinium-enhanced MR imaging and histopathologic findings. Radiology 1993, 186:813-817.
16. Present D, Bacchini P, Pignatti G, Picci P, Bertoni F, Campanacci M: Clear cell chondrosarcoma of bone. A report of 8 cases. Skeletal Radiol 1991, 20:187-191.
17. Bagley L, Kneeland JB, Dalinka MK, Bullough P, Brooks J: Unusual behavior of clear cell chondrosarcoma. Skeletal Radiol 1993, 22:279-282.
18. Masciocchi C, Sparvoli L, Barile A: Diagnostic imaging of malignant cartilage tumors. Eur J Radiol 1998, 27 Suppl 1:S86-90.
19. Wang XL, De Beuckeleer LH, De Schepper AM, Van Marck E: Low-grade chondrosarcoma vs enchondroma: challenges in diagnosis and management. Eur Radiol 2001, 11:1054-1057.
20. Sato O, Kawai A, Ozaki T, Kunisada T, Danura T, Inoue H: Value of thallium-201 scintigraphy in bone and soft tissue tumors. J Orthop Sci 1998, 3:297-303.
21. Lin J, Leung WT, Ho SK, Ho KC, Kumta SM, Metreweli C, Johnson PJ: Quantitative evaluation of thallium-201 uptake in predicting chemotherapeutic response of osteosarcoma. Eur J Nucl Med 1995, 22:553-555.
22. Caluser CI, Abdel-Dayem HM, Macapinlac HA, Scott A, Healey JH, Huvos A, Kalaigian H, Yeh SD, Larson SM: The value of thallium and three-phase bone scans in the evaluation of bone and soft tissue sarcomas. Eur J Nucl Med 1994, 21:1198-1205.
23. Menendez LR, Fideler BM, Mirra J: Thallium-201 scanning for the evaluation of osteosarcoma and soft- tissue sarcoma. A study of the evaluation and predictability of the histological response to chemotherapy. J Bone Joint Surg Am 1993, 75:526-531.
24. Daly MJ, Milutinovic J, Rudd TG, Phillips LA, Flalkow PJ: The normal 99mTc-DMSA renal image. Radiology 1978, 128:701-704.
25. Enlander D, Weber PM, dos Remedios LV: Renal cortical imaging in 35 patients: superior quality with 99mTc-DMSA. J Nucl Med 1974, 15:743-749.
26. Handmaker H, Young BW, Lowenstein JM: Clinical experience with 99mTc-DMSA (dimercaptosuccinic acid), a new renal-imaging agent. J Nucl Med 1975, 16:28-32.
27. Mojiminiyi OA, Udelsman R, Soper ND, Shepstone BJ, Dudley NE: Pentavalent Tc-99m DMSA scintigraphy. Prospective evaluation of its role in the management of patients with medullary carcinoma of the thyroid. Clin Nucl Med 1991, 16:259-262.
28. Hirano T, Otake H: Bone metastases demonstrated by pentavalent Tc-99m DMSA and Tc-99m HMDP. Clin Nucl Med 1997, 22:640-641.
29. Galloway RJ, Smallridge RC: Imaging in thyroid cancer. Endocrinol Metab Clin North Am 1996, 25:93-113.
30. Arslan N, Ilgan S, Yuksel D, Serdengecti M, Bulakbasi N, Ugur O, Ozguven MA: Comparison of In-111 octreotide and Tc-99m (V) DMSA scintigraphy in the detection of medullary thyroid tumor foci in patients with elevated levels of tumor markers after surgery. Clin Nucl Med 2001, 26:683-688.
31. Ohta H, Endo K, Koizumi M, Fujita T, Sakahara H, Nakashima T, Torizuka K, Hata N, Masuda H, Yomoda I, et al.: [Tumor imaging using Tc(V)-99m dimercaptosuccinic acid, a newly developed radiopharmaceutical: its clinical usefulness]. Kaku Igaku 1985, 22:1653-1660.
32. Clarke SE, Lazarus CR, Wraight P, Sampson C, Maisey MN: Pentavalent [99mTc]DMSA, [131I]MIBG, and [99mTc]MDP - an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid. J Nucl Med 1988, 29:33-38.
33. Ohnishi T, Noguchi S, Murakami N, Tajiri J, Morita M, Tamaru M, Hoshi H, Watanabe K: Pentavalent technetium-99m-DMSA uptake in a patient having multiple myeloma without amyloidosis. J Nucl Med 1991, 32:1785-1787.
34. Kobayashi H, Kotoura Y, Hosono M, Sakahara H, Yao ZS, Tsuboyama T, Yamamuro T, Endo K, Konishi J: Diagnostic value of Tc-99m (V) DMSA for chondrogenic tumors with positive Tc-99m HMDP uptake on bone scintigraphy. Clin Nucl Med 1995, 20:361-364.
35. Kashyap R, Babbar A, Sahai I, Prakash R, Soni NL, Chauhan UP: Tc-99m(V) DMSA imaging. A new approach to studying metastases from breast carcinoma. Clin Nucl Med 1992, 17:119-122.
36. Ogose A, Unni KK, Swee RG, May GK, Rowland CM, Sim FH: Chondrosarcoma of small bones of the hands and feet. Cancer 1997, 80:50-59.
37. Bovee JV, van der Heul RO, Taminiau AH, Hogendoorn PC: Chondrosarcoma of the phalanx: a locally aggressive lesion with minimal metastatic potential: a report of 35 cases and a review of the literature. Cancer 1999, 86:1724-1732.
38. Marco RA, Gitelis S, Brebach GT, Healey JH: Cartilage tumors: evaluation and treatment. J Am Acad Orthop Surg 2000, 8:292-304.
39. Choong PF, Sim FH: Limb-sparing surgery for bone tumors: new developments. Semin Surg Oncol 1997, 13:64-69.
40. Choong PF: Review article: Reconstructive surgery following resection of primary and secondary tumours of the hip. J Orthop Surg (Hong Kong) 2000, 8:83-94.
41. Bergh P, Gunterberg B, Meis-Kindblom JM, Kindblom LG: Prognostic factors and outcome of pelvic, sacral, and spinal chondrosarcomas: a center-based study of 69 cases. Cancer 2001, 91:1201-1212.
42. Bjornsson J, McLeod RA, Unni KK, Ilstrup DM, Pritchard DJ: Primary chondrosarcoma of long bones and limb girdles. Cancer 1998, 83:2105-2119.
43. Lee FY, Mankin HJ, Fondren G, Gebhardt MC, Springfield DS, Rosenberg AE, Jennings LC: Chondrosarcoma of bone: an assessment of outcome. J Bone Joint Surg Am 1999, 81:326-338.
44. Kalil RK, Inwards CY, Unni KK, Bertoni F, Bacchini P, Wenger DE, Sim FH: Dedifferentiated clear cell chondrosarcoma. Am J Surg Pathol 2000, 24:1079-1086.
45. Bauer HC, Brosjo O, Kreicbergs A, Lindholm J: Low risk of recurrence of enchondroma and low-grade chondrosarcoma in extremities. 80 patients followed for 2-25 years. Acta Orthop Scand 1995, 66:283-288.
46. Schreuder HW, Pruszczynski M, Veth RP, Lemmens JA: Treatment of benign and low-grade malignant intramedullary chondroid tumours with curettage and cryosurgery. Eur J Surg Oncol 1998, 24:120-126.
47. Tsuchiya H, Ueda Y, Morishita H, Nonomura A, Kawashima A, Fellinger EJ, Tomita K: Borderline chondrosarcoma of long and flat bones. J Cancer Res Clin Oncol 1993, 119:363-368.
48. Young CL, Sim FH, Unni KK, McLeod RA: Chondrosarcoma of bone in children. Cancer 1990, 66:1641-1648.